Report cover image

Cardiac Rhythm Management Market Size, Share, & COVID-19 Impact Analysis - Global - 2022-2028 - MedSuite - Includes: Pacemakers, Cardiac Ablation Catheters, and 6 more

Publisher iData Research, Inc.
Published Nov 24, 2022
Length 755 Pages
SKU # IDR17712752

Description

Cardiac Rhythm Management Market Size, Share, & COVID-19 Impact Analysis - Global - 2022-2028 - MedSuite - Includes: Pacemakers, Cardiac Ablation Catheters, and 6 more

The global cardiac rhythm management, electrophysiology & cardiac ablation market is valued at approximately $17.5 billion in 2021 and is expected to grow at a CAGR of 4.9% to reach over $24 billion during the forecast period. The full report suite on this market covers various products such as pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac leads, implantable loop recorders (ILRs), electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters, and cardiac ablation catheters. With an increasing demand for advanced medical devices for the treatment of heart diseases, the market for cardiac rhythm management, electrophysiology & cardiac ablation is poised for steady growth in the coming years.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2028, and Historical Data to 2018
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET TRENDS

The cardiac rhythm management and ablation sector is rapidly evolving with new technologies emerging on a regular basis. In the last decade, there have been significant improvements in the capabilities and battery lifespan of pacemakers and ICDs. Over the forecast period, the adoption of wireless technology is expected to make it easier for doctors to monitor and adjust the functions of these devices. This will likely result in higher sales of pacemakers and ICDs, as well as maintain high selling prices due to the incorporation of advanced technologies. The continued development and integration of new technologies will be a key driver of growth in this market in the coming years.

GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET SHARE INSIGHTS

The global cardiac rhythm management device market is dominated by three major players - Medtronic, Abbott, and Boston Scientific. Out of the more than 60 companies analyzed in this market, these three companies hold a significant market share and are recognized as the industry leaders.

Medtronic has maintained a strong presence in the total market for cardiac rhythm management (CRM), electrophysiology (EP) and ablation through brand recognition, strong customer support and a large sales force.

MARKET SEGMENTATION SUMMARY

While this report suite contains all global cardiac rhythm management devices data, each of the markets is also available as a stand-alone report, a MedCore.

Pacemaker Market – Includes:
Single-Chamber Pacemaker, Dual-Chamber Pacemaker, and Leadless Pacemaker
Implantable Cardioverter Defibrillator Market – Includes:
Single-Chamber ICD, Dual-Chamber ICD, and S-ICDs
Cardiac Resynchronization Therapy Device Market – Includes:
CRT-P, CRT-D
Cardiac Lead Market – Includes:
Pacing Lead, Defibrillation Lead, and LV Lead
Implant Loop Recorder Market
Electrophysiology Lab System Market – Includes:
3D Mapping System, EP Recording System
Diagnostic Electrophysiology Catheter Market – Includes:
Conventional EP Catheter, Advanced EP Catheter, and ICE Catheter
Cardiac Ablation Catheter Market – Includes:
RF Ablation Catheter, Cryoablation Catheter

RESEARCH SCOPE SUMMARY

Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2021
Forecast: 2021-2028
Historical Data: 2018-2021
Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE IDATA?

Experts Only– iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

Table of Contents

755 Pages
executive summary
Global Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedures Included
Markets Included
Regions Included
Version History
research methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
impact of covid-19 on THE global Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market
2.1 Introduction
2.2 Regional Profiles
2.3 Analysis By Market Segment
2.3.1 Worst Case Scenario
2.3.2 Base Case Scenario
2.3.3 Best Case Scenario
Disease Overview
3.1 Introduction
3.2 Types of Arrhythmias
3.2.11 Atrial Fibrillation
3.2.12 Bradycardia
3.2.13 Conduction Disorders
3.2.13.1 Bundle Branch Block
3.2.13.2 Heart Block
3.2.13.3 Long QT Syndrome (LQTS)
3.2.14 Premature Contractions: PACs and PVCs
3.2.15 Tachycardia
3.2.16 Ventricular Fibrillation
3.2.17 Other Rhythm Disorders
3.2.17.1 Adams-Stokes Disease
3.2.17.2 Atrial Flutter
3.2.17.3 Sick Sinus syndrome
3.2.17.4 Sinus Arrhythmia
3.2.17.5 Wolff-Parkinson-White Syndrome (WPW)
3.2.18 Types of Arrhythmia in Children
3.3 Heart Failure
3.4 Cardiac Arrest
3.5 Patient Demographics
3.5.11 Atrial Fibrillation
3.5.12 Bradycardia
3.5.13 Conduction Disorders
3.5.14 Premature Contractions – PACs and PVCs
3.5.15 Tachycardia
3.5.16 Ventricular Fibrillation
3.5.17 Other Rhythm Disorders
3.5.18 COVID & Arrhythmias
3.5.19 Heart Failure and Cardiac Arrest
Product Assessment
4.1 Introduction
4.2 Product Portfolios
4.2.1 Pacemakers
4.2.2 Implantable Cardioverter Defibrillators (ICDs)
4.2.3 Cardiac Resynchronization Therapy (CRT) Devices
4.2.4 Cardiac Leads
4.2.5 Implantable Loop Recorders
4.2.6 Electrophysiology Lab Systems
4.2.6.1 Introduction
4.2.6.2 3D Mapping Systems
4.2.6.3 EP Recording Systems
4.2.6.4 Remote Steering Systems
4.2.6.5 RF Ablation Generator
4.2.6.6 ICE Systems
4.2.7 Diagnostic EP Catheters
4.2.7.1 Introduction
4.2.7.2 Diagnostic EP Catheters
4.2.7.3 ICE Catheters
4.2.8 Cardiac Ablation Catheters
4.2.8.1 Introduction
4.2.8.2 RF Ablation Catheters
4.2.8.3 Alternative Energy Catheters
4.2.8.4 High Intensity Focused Ultrasound
4.3 Regulatory Issues and Recalls
4.3.1 Abbott
4.3.1.1 Pacemakers
4.3.1.2 Implantable Cardioverter Defibrillators (ICDs)
4.3.1.3 Cardiac Resynchronization Therapy (CRT) Devices
4.3.1.4 Cardiac Leads
4.3.1.5 EP Lab Devices
4.3.1.6 Cardiac Ablation Catheter
4.3.2 Biosense Webster
4.3.2.1 EP Lab Devices
4.3.2.2 Diagnostic EP Catheters
4.3.2.3 Cardiac Ablation Catheters
4.3.3 Boston Scientific
4.3.3.1 Pacemakers
4.3.3.2 Implantable Cardioverter Defibrillators (ICDs)
4.3.3.3 Cardiac Resynchronization Therapy (CRT) Devices
4.3.3.4 Cardiac Leads
4.3.3.5 EP Lab Devices
4.3.3.6 RF Ablation Catheter
4.3.4 Medtronic
4.3.4.1 Pacemakers
4.3.4.2 Implantable Cardioverter Defibrillators (ICDs)
4.3.4.3 Cardiac Resynchronization Therapy (CRT) Devices
4.3.4.4 Cardiac Leads
4.3.4.5 EP Lab Devices
4.3.5 MicroPort
4.3.5.1 Implantable Cardioverter Defibrillators (ICDs)
4.3.5.2 Cardiac Resynchronization Therapy (CRT) Devices
4.4 Clinical Trials
4.4.1 Pacemakers
4.4.2 Implantable Cardioverter Defibrillators (ICDs)
4.4.3 Cardiac Resynchronization Therapy (CRT) Devices
4.4.4 Cardiac Leads
4.4.5 Lab Systems
4.4.5.1 3D Mapping Systems
4.4.5.2 EP Recording Systems
4.4.5.3 RF Ablation Generators
4.4.5.4 ICE Systems
4.4.6 Diagnostic EP Catheters
4.4.6.1 Diagnostic Catheter
4.4.7 Cardiac Ablation Catheter
4.4.7.1 RF Ablation Catheters
4.4.7.2 Cryoablation Catheters
4.4.7.4 Laser Ablation Catheters
Global Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview
5.1 Introduction
5.2 Market Overview & Trend Analysis
5.2.1 By Segment
5.2.2 By Region
5.3 Drivers and Limiters
5.3.1 Market Drivers
5.3.2 Market Limiters
5.4 Competitive Market Share Analysis
5.5 Mergers and Acquisitions
5.6 Company Profiles
5.6.1 Abbott
5.6.2 Biosense Webster
5.6.3 Biotronik
5.6.4 Boston Scientific
5.6.5 GE Healthcare
5.6.6 Medtronic
5.6.7 MicroPort
5.7 SWOT Analysis
5.7.1 Abbott
5.7.2 Biosense Webster
5.7.3 Biotronik
5.7.4 Boston Scientific
5.7.5 GE Healthcare
5.7.6 Medtronic
5.7.7 MicroPort
Pacemaker Market
6.1 Executive Summary
6.1.1 Global Pacemaker Market Overview
6.1.2 Competitive Analysis
6.1.3 Procedures Included
6.1.4 Markets Included
6.1.5 Regions Included
6.2 Introduction
6.2.1 Single and Dual-Chamber Devices
6.2.2 MRI-Compatible Pacemaker
6.2.3 Leadless Pacemaker
6.2.4 Initial Placement and Replacement of Pacemakers
6.3 Procedure Numbers
6.3.1 Total Pacemaker Placement Procedures
6.3.2 Initial Placement Pacemaker Procedures
6.3.3 Replacement Pacemaker Procedures
6.4 Market Overview
6.4.1 By Segment
6.4.2 By Region
6.5 Market Analysis and Forecast
6.5.1 Total Pacemaker Market
6.5.2 Single-Chamber Pacemaker Market
6.5.2.1 Initial Placement Single-Chamber Pacemaker Market
6.5.2.2 Replacement Single-Chamber Pacemaker Market
6.5.3 Dual-Chamber Pacemaker Market
6.5.3.1 Initial Placement Dual-Chamber Pacemaker Market
6.5.3.2 Replacement Dual-Chamber Pacemaker Market
6.5.4 Leadless Pacemaker Market
6.5.4.1 Initial Placement Leadless Pacemaker Market
6.5.4.2 Replacement Leadless Pacemaker Market
6.6 Drivers and Limiters
6.6.1 Market Drivers
6.6.2 Market Limiters
6.7 Competitive Market Share Analysis
Implantable Cardioverter defibrillator Market
7.1 Executive Summary
7.1.1 Global Implantable Cardioverter Defibrillator Market Overview
7.1.2 Competitive Analysis
7.1.3 Procedures Included
7.1.4 Markets Included
7.1.5 Regions Included
7.2 Introduction
7.3 Procedure Numbers
7.3.1 Total ICD Placement Procedures
7.3.2 Initial Placement ICD Procedures
7.3.3 Replacement ICD Procedures
7.4 Market Overview
7.4.1 By Segment
7.4.2 By Region
7.5 Market Analysis and Forecast
7.5.1 Total ICD Market
7.5.2 Single-Chamber ICD Market
7.5.2.1 Initial Placement Single-Chamber ICD Market
7.5.2.2 Replacement Single-Chamber ICD Market
7.5.3 Dual-Chamber ICD Market
7.5.3.1 Initial Placement Dual-Chamber ICD Market
7.5.3.2 Replacement Dual-Chamber ICD Market
7.5.4 S-ICD Market
7.5.4.1 Initial Placement S-ICD Market
7.5.4.2 Replacement S-ICD Market
7.6 Drivers and Limiters
7.6.1 Market Drivers
7.6.2 Market Limiters
7.7 Competitive Market Share Analysis
Cardiac Resynchronization Therapy Device Market
8.1 Executive Summary
8.1.1 Global Cardiac Resynchronization Therapy Device Market Overview
8.1.2 Competitive Analysis
8.1.3 Procedures Included
8.1.4 Markets Included
8.1.5 Regions Included
8.2 Introduction
8.2.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps)
8.2.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds)
8.3 Procedure Numbers
8.3.1 Total CRT Placement Procedures
8.3.2 Initial Placement CRT Procedures
8.3.3 Replacement CRT Procedures
8.4 Market Overview
8.4.1 By Segment
8.4.2 By Region
8.5 Market Analysis and Forecast
8.5.1 Total CRT Device Market
8.5.2 CRT-P Market
8.5.2.1 Initial Placement CRT-P Market
8.5.2.2 Replacement CRT-P Market
8.5.3 CRT-D Market
8.5.3.1 Initial Placement CRT-D Market
8.5.3.2 Replacement CRT-D Market
8.6 Drivers and Limiters
8.6.1 Market Drivers
8.6.2 Market Limiters
8.7 Competitive Market Share Analysis
Cardiac Lead Market
9.1 Executive Summary
9.1.1 Global Cardiac Lead Market Overview
9.1.2 Competitive Analysis
9.1.3 Markets Included
9.1.4 Regions Included
9.2 Introduction
9.2.1 Replacement of Leads
9.3 Market Overview
9.3.1 By Segment
9.3.2 By Region
9.4 Market Analysis and Forecast
9.4.1 Total Cardiac Lead Market
9.4.2 Pacing Lead Market
9.4.3 Defibrillation Lead Market
9.4.4 LV Lead Market
9.5 Drivers and Limiters
9.5.1 Market Drivers
9.5.2 Market Limiters
9.6 Competitive Market Share Analysis
Implantable Loop Recorder Market
10.1 Executive Summary
10.1.1 Global Implantable Loop Recorder Market Overview
10.1.2 Competitive Analysis
10.1.3 Regions Included
10.2 Introduction
10.3 Procedure Numbers
10.4 Market Analysis and Forecast
10.5 Drivers and Limiters
10.5.1 Market Drivers
10.5.2 Market Limiters
10.6 Competitive Market Share Analysis
Electrophysiology Lab System Market
11.1 Executive Summary
11.1.1 Global Electrophysiology Lab System Market Overview
11.1.2 Competitive Analysis
11.1.3 Markets Included
11.1.4 Regions Included
11.2 Introduction
11.2.1 3D Mapping Systems
11.2.2 EP Recording Systems
11.3 Market Overview
11.3.1 By Segment
11.3.2 By Region
11.4 Market Analysis and Forecast
11.4.1 Total Electrophysiology Lab System Market
11.4.2 3D Mapping System Market
11.4.3 EP Recording System Market
11.5 Drivers and Limiters
11.5.1 Market Drivers
11.5.2 Market Limiters
11.6 Competitive Market Share Analysis
Diagnostic Electrophysiology Catheter Market
12.1 Executive Summary
12.1.1 Global Diagnostic Electrophysiology Catheter Market Overview
12.1.2 Competitive Analysis
12.1.3 Markets Included
12.1.4 Regions Included
12.2 Introduction
12.2.1 Diagnostic Electrophysiology Catheters
12.2.2 Intracardiac Echocardiography
12.3 Procedure Numbers
12.4 Market Overview
12.4.1 By Segment
12.4.2 By Region
12.5 Market Analysis and Forecast
12.5.1 Total Diagnostic Electrophysiology Catheter Market
12.5.2 Conventional Electrophysiology Catheter Market
12.5.3 Advanced Electrophysiology Catheter Market
12.5.4 ICE Catheter Market
12.6 Drivers and Limiters
12.6.1 Market Drivers
12.6.2 Market Limiters
12.7 Competitive Market Share Analysis
Cardiac Ablation Catheter Market
13.1 Executive Summary
13.1.1 Global Cardiac Ablation Catheter Market Overview
13.1.2 Competitive Analysis
13.1.3 Procedures Included
13.1.4 Markets Included
13.1.5 Regions Included
13.2 Introduction
13.3 Procedure Numbers
13.3.1 Total Cardiac Ablation Procedures
13.3.2 RF Ablation Procedures
13.3.3 Cryoablation Procedures
13.4 Market Overview
13.4.1 By Segment
13.4.2 By Region
13.5 Market Analysis and Forecast
13.5.1 Total Cardiac Ablation Catheter Market
13.5.2 RF Ablation Catheter Market
13.5.3 Cryoablation Catheter Market
13.6 Drivers and Limiters
13.6.1 Market Drivers
13.6.2 Market Limiters
13.7 Competitive Market Share Analysis
Abbreviations
LIST OF CHARTS
Chart 1-1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2021 – 2028
Chart 1-2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures, Global, 2021
Chart 2-1: Multi-Scenario Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Forecast, Global, 2018 – 2028 (US$M)
Chart 5-1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2018 – 2028
Chart 5-2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Region, Global, 2018 – 2028
Chart 5-3: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Global, 2021
Chart 6-1: Pacemaker Market, Global, 2018 – 2028
Chart 6-2: Pacemaker Placement Procedures, Global, 2021
Chart 6-3: Pacemaker Placement Procedures by Segment, Global, 2018 – 2028
Chart 6-4: Pacemaker Market by Segment, Global, 2018 – 2028
Chart 6-5: Pacemaker Market by Region, Global, 2018 – 2028
Chart 6-6: Leading Competitors, Pacemaker Market, Global, 2021
Chart 7-1: ICD Market, Global, 2018 – 2028
Chart 7-2: ICD Placement Procedures, Global, 2021
Chart 7-3: ICD Placement Procedures by Segment, Global, 2018 – 2028
Chart 7-4: ICD Market by Segment, Global, 2018 – 2028
Chart 7-5: ICD Market by Region, Global, 2018 – 2028
Chart 7-6: Leading Competitors, ICD Market, Global, 2021
Chart 8-1: CRT Device Market, Global, 2018 – 2028
Chart 8-2: CRT Device Placement Procedures, Global, 2021
Chart 8-3: CRT Placement Procedures by Segment, Global, 2018 – 2028
Chart 8-4: CRT Device Market by Segment, Global, 2018 – 2028
Chart 8-5: CRT Device Market by Region, Global, 2018 – 2028
Chart 8-6: Leading Competitors, CRT Device Market, Global, 2021
Chart 9-1: Cardiac Lead Market, Global, 2018 – 2028
Chart 9-2: Cardiac Lead Units Sold, Global, 2021
Chart 9-3: Cardiac Lead Market by Segment, Global, 2018 – 2028
Chart 9-4: Cardiac Lead Market by Region, Global, 2018 – 2028
Chart 9-5: Leading Competitors, Cardiac Lead Market, Global, 2021
Chart 10-1: Implantable Loop Recorder Market, Global, 2018 – 2028
Chart 10-2: Implantable Loop Recorder Placement Procedures, Global, 2021
Chart 10-3: Implantable Loop Recorder Placement Procedures by Region, Global, 2018 – 2028
Chart 10-4: Implantable Loop Recorder Device Market, Global, 2018 – 2028
Chart 10-5: Leading Competitors, Implantable Loop Recorder Market, Global, 2021
Chart 11-1: Electrophysiology Lab System Market, Global, 2018 – 2028
Chart 11-2: Electrophysiology Lab System Procedures, Global, 2021
Chart 11-3: Electrophysiology Lab System Market by Segment, Global, 2018 – 2028
Chart 11-4: Electrophysiology Lab System Market by Region, Global, 2018 – 2028
Chart 11-5: Leading Competitors, Electrophysiology Lab System Market, Global, 2021
Chart 12-1: Diagnostic Electrophysiology Catheter Market, Global, 2018 – 2028
Chart 12-2: Diagnostic Electrophysiology Catheter Procedures, Global, 2021
Chart 12-3: Diagnostic Electrophysiology Procedures, Global, 2018 – 2028
Chart 12-4: Diagnostic Electrophysiology Catheter Market by Segment, Global, 2018 – 2028
Chart 12-5: Diagnostic Electrophysiology Catheter Market by Region, Global, 2018 – 2028
Chart 12-6: Leading Competitors, Diagnostic Electrophysiology Catheter Market, Global, 2021
Chart 13-1: Cardiac Ablation Catheter Market, Global, 2018 – 2028
Chart 13-2: Cardiac Ablation Catheter Procedures, Global, 2021
Chart 13-3: Cardiac Ablation Procedures by Segment, Global, 2018 – 2028
Chart 13-4: Cardiac Ablation Catheter Market by Segment, Global, 2018 – 2028
Chart 13-5: Cardiac Ablation Catheter Market by Region, Global, 2018 – 2028
Chart 13-6: Leading Competitors, Cardiac Ablation Catheter Market, Global, 2021
LIST OF FIGURES
Figure 1-1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, Global, 2021 (1 of 2)
Figure 1-2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, Global, 2021 (2 of 2)
Figure 1-3: Companies Researched in this Report
Figure 1-4: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global (1 of 2)
Figure 1-5: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global (2 of 2)
Figure 1-6: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Global, 2018 – 2022 (1 of 2)
Figure 1-7: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Global, 2018 – 2022 (2 of 2)
Figure 1-8: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures Covered
Figure 1-9: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered (1 of 2)
Figure 1-10: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered (2 of 2)
Figure 1-11: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Regions Covered, Global (1 of 2)
Figure 1-12: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Regions Covered, Global (2 of 2)
Figure 1-13: Version History
Figure 2-1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Worst Case Scenario, Global, 2018 – 2028 (US$M)
Figure 2-2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Base Case Scenario, Global, 2018 – 2028 (US$M)
Figure 2-3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Best Case Scenario, Global, 2018 – 2028 (US$M)
Figure 4-1: Pacemaker Market Products by Company
Figure 4-2: ICD Market Products by Company
Figure 4-3: CRT Device Market Products by Company (1 of 2)
Figure 4-4: CRT Device Market Products by Company (2 of 2)
Figure 4-5: Cardiac Lead Market Products by Company
Figure 4-6: Implantable Loop Recorder Market Products by Company
Figure 4-7: EP Lab System Market Products by Company
Figure 4-8: Diagnostic EP Catheter Market Products by Company
Figure 4-9: Cardiac Ablation Catheter Products by Company (1 of 2)
Figure 4-10: Cardiac Ablation Catheter Products by Company (2 of 2)
Figure 4-11: Class 1 Device Recall Assurity pacemakers
Figure 4-12: Class 1 Device Recall St. Jude Endurity Pacemakers
Figure 4-13: Class 1 Device Recall Fortify, Unify, Assura, including Quadra
Figure 4-14: Class 2 Device Recall Ellipse
Figure 4-15: Class 2 Device Recall Quadra Assura
Figure 4-16: Class 2 Device Recall Unify Assura
Figure 4-17: Class 2 Device Recall Unify Quadra
Figure 4-18: Class 2 Device Recall Promote Quadra
Figure 4-19: Class 2 Device Recall Allure Quadra
Figure 4-20: Class 2 Device Recall Allure Quadra
Figure 4-21: Class 2 Device Recall Anthem, Allure
Figure 4-22: Class 2 Device Recall Nuance
Figure 4-23: Class 1 Device Recall Optisure HV lead
Figure 4-24: Class 2 Device Recall FIRMap
Figure 4-25: Class 2 Device Recall WorkMate Claris, v.1.2 Upgrade Kits
Figure 4-26: Class 3 Device Recall FIRMap 60mm Catheter
Figure 4-27: Class 2 Device Recall Abbott
Figure 4-28: Class 2 Device Recall TactiSys Quartz Pack, PN004 400
Figure 4-29: Class 2 Device Recall CARTO 3 System
Figure 4-30: Class 2 Device Recall SMARTABLATE RF Generator System
Figure 4-31: Class 2 Device Recall ACUSON AcuNav Volume ICE Catheter
Figure 4-32: Class 2 Device Recall PENTARAY NAV eco HighDensity Mapping Catheter
Figure 4-33: Class 2 Device Recall PENTARAY NAV HighDensity Mapping Catheter
Figure 4-34: Class 2 Device Recall SOUNDSTAR eco Catheter
Figure 4-35: Class 2 Device Recall WEBSTER Fixed Curve Catheter with Auto ID Technology
Figure 4-36: Class 2 Device Recall THERMOCOOL SMARTTOUCH
Figure 4-37: Class 1 Device Recall ADVANTIO DR EL
Figure 4-38: Class 1 Device Recall INGENIO DR EL
Figure 4-39: Class 1 Device Recall VITALIO DR EL
Figure 4-40: Class 2 Device Recall Accolade
Figure 4-41: Class 2 Device Recall Essentio
Figure 4-42: Class 2 Device Recall EMBLEM
Figure 4-43: Class 1 Device Recall EMBLEM
Figure 4-44: Class 2 Device Recall ESSENTIO Pacemaker
Figure 4-45: Class 2 Device Recall PROPONENT Pacemaker
Figure 4-46: Class 2 Device Recall ACCOLADE Pacemaker
Figure 4-47: Class 2 Device Recall ACCOLADE MRI Pacemaker
Figure 4-48: Class 2 Device Recall ESSENTIO MRI Pacemaker
Figure 4-49: Class 2 Device Recall ESSENTIO Pacemaker
Figure 4-50: Class 2 Device Recall PROPONENT Pacemaker
Figure 4-51: Class 2 Device Recall PROPONENT MRI Pacemaker
Figure 4-52: Class 2 Device Recall ALTRUA 2 EL DR Pacemaker
Figure 4-53: Class 2 Device Recall ALTRUA 2 SR Pacemaker
Figure 4-54: Class 2 Device Recall ALTRUA 2 DR Pacemaker
Figure 4-55: Class 2 Device Recall Accolade MRI and Essentio MRI pacemakers
Figure 4-56: Class 2 Device Recall EMBLEM
Figure 4-57: Class 2 Device Recall EMBLEM
Figure 4-58: Class 1 Device Recall EMBLEM
Figure 4-59: Class 2 Device Recall DYNAGEN EL ICD DR
Figure 4-60: Class 2 Device Recall Implantable Cardioverter Defibrillator (NonCRT)
Figure 4-61: Class 2 Device Recall RESONATE EL ICD VR/DR
Figure 4-62: Class 2 Device Recall EMBLEM SICD, Model A209
Figure 4-63: Class 2 Device Recall SQRX 1010 Pulse Generator
Figure 4-64: Class 2 Device Recall EMBLEM MRI SICD Model 219
Figure 4-65: Class 2 Device Recall SQRX Model 1010 Subcutaneous Pulse Generator
Figure 4-66: Class 1 Device Recall INTUA CRTP
Figure 4-67: Class 1 Device Recall INVIVE CRTP
Figure 4-68: Class 2 Device Recall VISIONIST CRTP
Figure 4-69: Class 2 Device Recall VALITUDE CRTP
Figure 4-70: Class 2 Device Recall VALITUDE X4 CRTP (Cardiac Resynchronization Therapy Pacemaker)
Figure 4-71: Class 2 Device Recall VALITUDE X4 CRTP Pacemaker
Figure 4-72: Class 2 Device Recall VALITUDE CRTP Pacemaker
Figure 4-73: Class 2 Device Recall VISIONIST X4 CRTP Pacemaker
Figure 4-74: Class 2 Device Recall VISIONIST CRTP Pacemaker
Figure 4-75: Class 2 Device Recall RESONATE X4 CRTD
Figure 4-76: Class 2 Device Recall MOMENTUM X4 CRTD
Figure 4-77: Class 2 Device Recall VIGILANT X4 CRTD
Figure 4-78: Class 2 Device Recall Boston Scientific, INGEVITY MRI Leads, Sterile EO, RxOnly
Figure 4-79: Class 2 Device Recall iLab Polaris MultiModality Guidance System
Figure 4-80: Class 2 Device Recall Maestro 4000 Cardiac Ablation System
Figure 4-81: Class 2 Device Recall CLEARSIGN II Amplifier for LABSYSTEM PRO EP Recording System
Figure 4-82: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters
Figure 4-83: Class 1 Device Recall Intella Tip MiFi Open Irrigated Ablation Catheter
Figure 4-84: Class 2 Device Recall Astra XT DR Implantable pulse generator
Figure 4-85: Class 2 Device Recall Azure
Figure 4-86: Class 2 Device Recall Azure XT DR MRI
Figure 4-87: Class 2 Device Recall Azure S DR MRI
Figure 4-88: Class 2 Device Recall Azure XT SR MRI
Figure 4-89: Class 2 Device Recall Azure S SR MRI
Figure 4-90: Class 2 Device Recall Medtronic Micra MC1VR01
Figure 4-91: Class 1 Device Recall SPHERA, Dual chamber pacemaker
Figure 4-92: Class 1 Device Recall SENSIA, Dual chamber pacemaker
Figure 4-93: Class 1 Device Recall VERSA, Dual chamber pacemaker
Figure 4-94: Class 1 Device Recall ADAPTA, Dual chamber pacemaker
Figure 4-95: Class 1 Device Recall ATTESTA L DR MRI SureScan, Dual chamber rate responsive pacemaker
Figure 4-96: Class 2 Device Recall Medtronic Model 53401 Single Chamber External Pulse Generator
Figure 4-97: Class 2 Device Recall Medtronic Model 5392 Dual Chamber Temporary External Pulse Generator
Figure 4-98: Class 1 Device Recall Cobalt
Figure 4-99: Class 1 Device Recall Crome
Figure 4-100: Class 1 Device Recall Evera and Visia
Figure 4-101: Class 2 Device Recall EnTrust Dual Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies
Figure 4-102: Class 2 Device Recall EnTrust Single Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies
Figure 4-103: Class 2 Device Recall Medtronic EnTrust Escudo
Figure 4-104: Class 1 Device Recall Evera MRI XT DR ICD, Evera MRI XT VR ICD, Evera MRI S DR ICD
Figure 4-105: Class 1 Device Recall Visia AF MRI VR SureScan ICD
Figure 4-106: Class 1 Device Recall Visia AF VR ICD
Figure 4-107: Class 1 Device Recall Evera S DR ICD, Evera S VR ICD, Evera XT DR ICD, Evera XT VR ICD
Figure 4-108: Class 2 Device Recall Evera ICD
Figure 4-109: Class 2 Device Recall Viva ICD
Figure 4-110: Class 1 Device Recall Cobalt
Figure 4-111: Class 1 Device Recall Crome
Figure 4-112: Class 2 Device Recall Cobalt
Figure 4-113: Class 2 Device Recall Precepta
Figure 4-114: Class 2 Device Recall Percepta, Serena, and Solara CRTP MRI
Figure 4-115: Class 1 Device Recall Viva, Claria, Amplia, Compia, and Brava
Figure 4-116: Class 2 Device Recall Percepta CRTP MRI
Figure 4-117: Class 2 Device Recall Solara CRTP MRI
Figure 4-118: Class 2 Device Recall Serena CRTP MRI
Figure 4-119: Class 2 Device Recall Percepta CRTP MRI SureScan
Figure 4-120: Class 2 Device Recall Percepta Quad CRTP MRI SureScan
Figure 4-121: Class 1 Device Recall Amplia MRI CRTD, Amplia MRI Quad CRTD
Figure 4-122: Class 1 Device Recall Viva Quad S CRTD, Viva Quad XT CRTD, Viva S CRTD, Viva XT CRTD
Figure 4-123: Class 1 Device Recall Compia MRI CRTD, Compia MRI Quad CRTD
Figure 4-124: Class 2 Device Recall Amplia MRI Quad CRT0 SureScanClaria MRI Quad CRTD SureScanCompia MRI Quad CRTD SureScan
Figure 4-125: Class 2 Device Recall InSync III
Figure 4-126: Class 2 Device Recall Sprint Quattro
Figure 4-127: Class 2 Device Recall Medtronic, Temporary Pacing Lead System
Figure 4-128: Class 2 Device Recall Achieve Electrical Cable
Figure 4-129: Class 2 Device Recall Medtronic CryoConsole
Figure 4-130: Class 2 Device Recall Platinium Implantable Cardiac Defibrillator and Resynchronization Therapy Defibrillator
Figure 4-131: Class 2 Device Recall Platinium DR 1510
Figure 4-132: Class 2 Device Recall Platinium VR 1210
Figure 4-133: Class 2 Device Recall Platinium DR DF4 1540
Figure 4-134: Class 2 Device Recall Platinium VR DF4 1240
Figure 4-135: Class 2 Device Recall PARADYM
Figure 4-136: Class 2 Device Recall OVATIO
Figure 4-137: Class 2 Device Recall INTENSIA
Figure 4-138: Class 2 Device Recall Platinium Implantable Cardiac Defibrillator and Resynchronization Therapy Defibrillator
Figure 4-139: Class 2 Device Recall Platinium CRTD 1741
Figure 4-140: Class 2 Device Recall Platinium CRT DF1 1711
Figure 4-141: Class 2 Device Recall PARADYM
Figure 4-142: Class 2 Device Recall OVATIO
Figure 4-143: Class 2 Device Recall INTENSIA
Figure 4-144: The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System
Figure 4-145: Aveir VR Coverage With Evidence Development Post-Approval Study (CED)
Figure 4-146: A Retrospective Trial to Evaluate the Micra Pacemaker (Micra)
Figure 4-147: Project My Heart Your Heart: Pacemaker Reuse (MHYH)
Figure 4-148: Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular Block Patients After Pacemaker Implantation (AF-pacemaker Study)
Figure 4-149: Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers
Figure 4-150: Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan
Figure 4-151: BIO|MASTER.Edora Family Study
Figure 4-152: China Micra Transcatheter Pacing Study
Figure 4-153: Optimizing Pacemaker Therapy Using Multi-Point Pacing (the OPT-MPP Study)
Figure 4-154: Electrical Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation - The CAPAPAF-65 Study
Figure 4-155: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II
Figure 4-156: Observation of ImageReady™ MR Conditional Pacing System in China
Figure 4-157: Micra Transcatheter Pacing System Continued Access Study Protocol
Figure 4-158: Extravascular ICD Pivotal Study (EV ICD)
Figure 4-159: Defibrillation Testing During Implantable Cardioverter Defibrillator (ICD) Replacement (T-DEF)
Figure 4-160: Master Study of the Acticor/Rivacor ICDs/CRT-Ds and the Plexa ProMRI S DX Lead
Figure 4-161: A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD System on Patients Undergoing Magnetic Resonance Imaging (ASIA MRI ICD)
Figure 4-162: Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing (MODULAR ATP)
Figure 4-163: Acute Feasibility Investigation of a New S-ICD Electrode (ASE)
Figure 4-164: Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED)
Figure 4-165: A PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator Therapy (PRAETORIAN)
Figure 4-166: Comparison of CRT-D and CRT-DX Systems (CRT-NEXT)
Figure 4-167: Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients with the Use of a VDD-ICD Lead (Dx-AF)
Figure 4-168: Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD)
Figure 4-169: Extravascular ICD Pilot Study
Figure 4-170: Acute Feasibility Investigation of a New S-ICD Electrode
Figure 4-171: Subcutaneous ICD Therapy Combined with VT Ablation for the Secondary Prevention of Sudden Cardiac Death
Figure 4-172: BIO|MASTER.Ilivia Family/Plexa
Figure 4-173: Metabolic Mapping and Cardiac Resynchronization
Figure 4-174: CRT-P or CRT-D in Dilated Cardiomyopathy (CRT-REALITY)
Figure 4-175: Safety and Performance Aspects of CRT-DX System in Patients with Sinus Rhythm (BIO|REDUCE)
Figure 4-176: Prospective Randomized Trial Comparing TRIPLE Site ventricular Stimulation Versus Conventional Pacing in CRT candidates: TRIPLEAD Trial
Figure 4-177: Re-evaluation of Optimal Re-synchronization Therapy in Patients with Chronic Heart Failure
Figu

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us